Ads
related to: prostate cancer vaccine update
Search results
Pharma Stock Roundup: LLY's 2023 View, MRK-MRNA Joint Cancer Vaccine Data & More
Zacks via Yahoo Finance· 1 year agoEli Lilly (LLY) gives its financial guidance for 2023. Merck (MRK) and Moderna's (MRNA) mRNA-based...
Pharma Stock Roundup: MRK Buys Cancer Drug Rights, SNY Dupixent Kids Study Succeeds
Zacks via Yahoo Finance· 2 years agoThis week, Merck MRK in-licensed co-development rights to Orion Corporation’s prostate cancer...
Better Buy: Novavax or BioNTech Stock?
Motley Fool· 1 year agoLast week, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the Food and Drug Administration (FDA) recommended a move toward a...
Pharma Stock Roundup: FDA Okays PFE RSV Jab for Elderly, AZN Ends Brazikumab Studies
Zacks via Yahoo Finance· 1 year agoFDA approves Pfizer's (PFE) RSV vaccine for older adults and AstraZeneca (AZN) and Merck's (MRK)...
15 Deadliest Cancers in the U.S.
Insider Monkey via Yahoo Finance· 11 months agoIn this article, we will discuss the 15 deadliest cancers in the U.S. To skip our detailed analysis and recent updates regarding cancer research and the...
Pharma Stock Roundup: PFE Gets Nod for RSV Vaccine, J&J Finalizes Kenvue Separation
Zacks via Yahoo Finance· 9 months agoFDA and EU approve Pfizer's (PFE) RSV vaccine, Abrysvo for maternal immunization. J&J (JNJ)...
Sexually-Active Gay Men: Here's What to Ask at Your Annual Physical
Plus via Yahoo News· 1 year agoThe end of the year or the start of a new one is typically called the "annual physical" season as...
Al Roker's Health Journey Over the Years, in His Own Words
People via Yahoo News· 2 years agoFrom his bypass surgery to his prostate cancer diagnosis, the Today show weather anchor has been...
Pfizer (PFE) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 months agoImage source: The Motley Fool. Pfizer (NYSE: PFE) Q4 2023 Earnings Call Jan 30, 2024, 10:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
Pharma Stock Roundup: End of SNY's Amcenestrant Development, FDA Updates for AZN, GSK
Zacks via Yahoo Finance· 2 years agoSanofi (SNY) ends the development of breast cancer candidate, amcenestrant. Novartis' (NVS) lung...